Items where authors include "Bownes, P"

Article

Zhong, J orcid.org/0000-0001-5325-3739, Brown, S orcid.org/0000-0002-7975-7537, Serra, M et al. (17 more authors) (2022) Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT). BMJ Open, 12 (11). e068580. ISSN 2044-6055

Slevin, F, Sethugavalar, B, Al-Qaisieh, B et al. (5 more authors) (2020) Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer. Journal of Contemporary Brachytherapy, 12 (6). pp. 540-546. ISSN 1689-832X

Slevin, F, Rodda, SL, Bownes, P et al. (10 more authors) (2020) Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’. Clinical and Translational Radiation Oncology, 24. p. 52. ISSN 2405-6308

Slevin, F, Hodgson, S, Rodda, SL et al. (9 more authors) (2020) Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer. Clinical and Translational Radiation Oncology, 23. pp. 20-26. ISSN 2405-6308

Mason, J, Henry, A orcid.org/0000-0002-5379-6618 and Bownes, P (2020) Error detection thresholds for routine real time in vivo dosimetry in HDR prostate brachytherapy. Radiotherapy and Oncology. ISSN 0167-8140

Slevin, F, Rodda, SL, Bownes, P et al. (10 more authors) (2020) A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy. Clinical and Translational Radiation Oncology, 20. pp. 1-8. ISSN 2405-6308

Mason, J, Adiotomre, E, Bownes, P et al. (2 more authors) (2018) Importance of dynamic contrast enhanced magnetic resonance imaging for targeting biopsy and salvage treatments after prostate cancer recurrence. Journal of Contemporary Brachytherapy, 10 (6). pp. 570-572. ISSN 1689-832X

Murray, L orcid.org/0000-0003-0658-6455, Mason, J, Henry, AM orcid.org/0000-0002-5379-6618 et al. (4 more authors) (2016) Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer. Radiotherapy and Oncology, 120 (2). pp. 293-299. ISSN 0167-8140

Mason, J, Mamo, A, Al-Qaisieh, B et al. (2 more authors) (2016) Real-time in vivo dosimetry in high dose rate prostate brachytherapy. Radiotherapy and Oncology, 120 (2). pp. 333-338. ISSN 0167-8140

Mason, J, Bownes, P, Carey, B et al. (1 more author) (2015) Comparison of focal boost high dose rate prostate brachytherapy optimisation methods. Radiotherapy and Oncology, 117 (3). pp. 521-524. ISSN 0167-8140

Henry, AM, Rodda, SL, Mason, M et al. (7 more authors) (2015) The Effect of Dose and Quality Assurance in Early Prostate Cancer Treated with Low Dose Rate Brachytherapy as Monotherapy. Clinical Oncology, 27 (7). 382 - 386. ISSN 0936-6555